Literature DB >> 2972531

Determinants of atrial natriuretic factor in the adult respiratory distress syndrome.

H B Eison1, M J Rosen, R A Phillips, L R Krakoff.   

Abstract

We measured plasma atrial natriuretic factor over the clinical course of 12 patients with the adult respiratory distress syndrome (ARDS). A total of 33 sequential measurements were correlated with 23 hemodynamic, pulmonary, and renal parameters. Atrial natriuretic factor was found to be eight times higher than age-matched healthy control subjects (p = 0.001). Although atrial natriuretic factor correlated well with pulmonary capillary wedge pressure (r = 0.592), there was no significant relationship between right atrial pressure and plasma atrial natriuretic factor (r = 0.258). Atrial natriuretic factor was best related to pulmonary artery systolic pressure (r = 0.751). We conclude that in ARDS, plasma atrial natriuretic factor is markedly elevated and arterial levels are best determined by left atrial pressure and pulmonary hemodynamics, and not by right sided cardiac pressures. The role of increased circulating atrial natriuretic factor in the pathophysiology of ARDS is to be clarified in future studies.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2972531     DOI: 10.1378/chest.94.5.1040

Source DB:  PubMed          Journal:  Chest        ISSN: 0012-3692            Impact factor:   9.410


  9 in total

1.  Opposite effects of ANP receptors in attenuation of LPS-induced endothelial permeability and lung injury.

Authors:  Junjie Xing; Bakhtiyor Yakubov; Valeriy Poroyko; Anna A Birukova
Journal:  Microvasc Res       Date:  2011-10-06       Impact factor: 3.514

2.  Atrial natriuretic peptide protects against Staphylococcus aureus-induced lung injury and endothelial barrier dysfunction.

Authors:  Junjie Xing; Nurgul Moldobaeva; Anna A Birukova
Journal:  J Appl Physiol (1985)       Date:  2010-11-04

Review 3.  Diastolic function in hypertension.

Authors:  R A Phillips; J A Diamond
Journal:  Curr Cardiol Rep       Date:  2001-11       Impact factor: 2.931

4.  ANP attenuates inflammatory signaling and Rho pathway of lung endothelial permeability induced by LPS and TNFalpha.

Authors:  Junjie Xing; Anna A Birukova
Journal:  Microvasc Res       Date:  2009-11-26       Impact factor: 3.514

5.  Prognostic value of plasma N-terminal probrain natriuretic peptide levels in the acute respiratory distress syndrome.

Authors:  Ednan K Bajwa; James L Januzzi; Michelle N Gong; B Taylor Thompson; David C Christiani
Journal:  Crit Care Med       Date:  2008-08       Impact factor: 7.598

6.  Neutral endopeptidase (NEP) inhibition in rats with established pulmonary hypertension secondary to chronic hypoxia.

Authors:  J S Thompson; W Sheedy; A H Morice
Journal:  Br J Pharmacol       Date:  1994-12       Impact factor: 8.739

7.  Glucagon-Like Peptide 1 and Atrial Natriuretic Peptide in a Female Mouse Model of Obstructive Pulmonary Disease.

Authors:  Emilie Balk-Møller; Johanne Agerlin Windeløv; Berit Svendsen; Jenna Hunt; Seyed Mojtaba Ghiasi; Charlotte Mehlin Sørensen; Jens Juul Holst; Hannelouise Kissow
Journal:  J Endocr Soc       Date:  2019-12-19

8.  Atrial natriuretic peptide attenuates agonist-induced pulmonary edema in mice with targeted disruption of the gene for natriuretic peptide receptor-A.

Authors:  James R Klinger; Shu-Whei Tsai; Sabrina Green; Katie L Grinnell; Jason T Machan; Elizabeth O Harrington
Journal:  J Appl Physiol (1985)       Date:  2012-11-29

9.  Elevated plasma levels of endothelin are associated with the severity of sepsis and presence of shock in contrast to the levels of atrial natriuretic peptide.

Authors:  A Beishuizen; J M Götz; L Kip; C Haanen; I Vermes
Journal:  Mediators Inflamm       Date:  1992       Impact factor: 4.711

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.